Biogen Inc
NASDAQ: BIIB
$199.36
-$2.08 (-1.0%)
Closing Price on September 20, 2024
BIIB Articles
Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term, and the sector that rated highest was biotechnology.
Published:
Last Updated:
The September 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in...
Published:
Last Updated:
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
The July 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Biogen released better-than-expected second-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday included Apple, Biogen, BJ's Wholesale, ConocoPhillips, Honeywell, Schlumberger, Shopify and Spotify.
Published:
Last Updated:
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
Published:
Last Updated:
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include American Tower, AutoNation, Biogen, CarMax, Chipotle Mexican Grill, eBay, PG&E, Walgreens and Zions Bancorp.
Published:
Last Updated:
Friday was a positive day for the broad U.S. markets, closing out an ultimately positive but shortened week. Crude oil bounced back on the day. The S&P 500 sectors were entirely positive.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Apple, Biogen, Costco, Kroger, Humana and Patterson-UTI.
Published:
Last Updated:
Biogen shares jumped early on Friday after the firm, in conjunction with Eisai, announced positive results from a midstage Alzheimer’s study.
Published:
Last Updated: